Potential of the rat model of conditioned gaping to detect nausea produced by rolipram, a phosphodiesterase-4 (PDE4) inhibitor

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 4, 2009, Pages 537-541

  Rock, Erin M ^a   Benzaquen, Jessica ^a   Limebeer, Cheryl L ^a   Parker, Linda A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Conditioning; Learning; Nausea; Rat; Rolipram

Indexed keywords

ROLIPRAM; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG SCREENING; LEARNING; MALE; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RAT; TASTE ACUITY; VOMITING;

ANIMALS; CONDITIONING, OPERANT; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; MALE; MOTOR ACTIVITY; NAUSEA; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; ROLIPRAM;

RATTUS;

EID: 58349114835     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.09.005     Document Type: Article

References (26)

1. Ballatori E., Roila F., Ruggeri B., Betti M., Sarti S., Soru G., et al. The impact of chemotherapy-induced nausea and vomiting on health-related quality of life. Support Care Cancer 15 (2007) 179-185
2. Barad M., Bourtchouladze R., Winder D.G., Golan H., and Kandel E. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci U S A 95 (1998) 15020-15025
3. Bertolino A., Crippa D., Di Dio S., Fichte K., Musmeci G., Porro V., et al. Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach. Int Clin Psychopharm 3 (1988) 245-253
4. Bureau Y., Handa M., Zhu Y., Laliberte F., Moore C.S., Liu S., et al. Neuroanatomical and pharmacological assessment of Fos expression induced in the rat brain by phosphodiesterase-4 inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline. Neuropharmacol 51 (2006) 974-985
5. Foubert J., and Vaessen G. Nausea: the neglected symptom?. Eur J Oncol Nurs 9 (2005) 21-32
6. Grill H.J., and Norgren R. The taste reactivity test: I. Mimetic responses to gustatory stimuli in neurologically normal rats. Brain Res 143 (1978) 263-279
7. Griffin A.M., Butow P.N., Coates A.S., Childs A.M., Ellis P.M., Dunn S.M., et al. On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7 (1996) 189-195
8. Heaslip R.J., and Evans D.Y. Emetic, central nervous system and pulmonary activities of rolipram in the dog. Eur J Pharmacol 286 (1995) 281-290
9. Hebenstreit G.F., Fellerer K., Fichte K., Fischer G., Geyer N., Meya U., et al. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine. Pharmacopsychiatry 22 (1989) 156-160
10. Hirose R., Manabe H., Nonaka H., Yanagawa K., Akuta K., Sato S., et al. Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain. Eur J Pharmacol 573 (2007) 93-99
11. Houslay M.D., Schafer P., and Zhang K.Y.J. Phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10 (2005) 1503-1519
12. Krebs E.G., and Beavo J.A. Phosphorylation-dephosphorylation of enzymes. Annu Rev Biochem 48 (1979) 923-959
13. Limebeer C.L., Hall G., and Parker L.A. Exposure to a lithium-paired context elicits gaping in rats: a model of anticipatory nausea. Physiol Behav 88 (2006) 398-403
14. Limebeer C.L., Krohn J.P., Cross-Mellor S., Litt D.E., Ossenkop K.P., and Parker L.A. Exposure to a context previously associated with nausea elicits conditioned gaping in rats: a model of anticipatory nausea. Behav Brain Res 187 (2008) 33-40
15. Limebeer C.L., and Parker L.A. The antiemetic drug ondansetron interferes with lithium-induced conditioned rejection reactions, but not lithium-induced taste avoidance in rats. J Exp Psychol Anim Behav Process 26 (2000) 371-384
16. Parker L.A. Rewarding drugs produce taste avoidance, but not taste aversion. Neurosci Biobehav Rev 19 (1995) 143-157
17. Parker L.A. Taste avoidance and taste aversion: evidence for two different processes. Learn Behav 31 (2003) 165-172
18. Parker L.A., and Limebeer C.L. Conditioned gaping in rats: a selective measure of nausea. Autonom Neuros: Basic Clin 129 (2006) 36-41
19. Parker L.A., Mechoulam R., Schlievert C., Abbott L., Fudge M.L., and Burton P. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Psychopharmacology 166 (2003) 156-162
20. Parkes J.D., Thompson C., Brennan L., Gajraj N., Howcroft B., and Ruiz J. Rolipram in Parkinson's disease. Adv Neurol 40 (1984) 563-565
21. Robichaud A., Savoie C., Stamatiou P.B., Tattersall F.D., and Chan C.C. PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway. Neuropharmacology 40 (2001) 262-269
22. Robichaud A., Tattersall F.D., Choudhury I., and Rodger I.W. Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret. Neuropharmacology 38 (1999) 289-297
23. Travers J.B., and Norgren R. Electromyographic analysis of the ingestion and rejection of sapid stimuli in the rat. Behav Neurosci 100 (1986) 544-555
24. Wachtel H. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology 22 (1983) 267-272
25. Zalaquett C.T., and Parker L.A. Further evidence that CTAs produced by lithium and amphetamine are qualitatively different. Learn Motiv 20P (1989) 413-427
26. Zeller E., Stief H.J., Pflug B., and Sastre-y-Hernández M. Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiatry 17 (1984) 188-190